HomeComparePTNR vs JNJ

PTNR vs JNJ: Dividend Comparison 2026

PTNR yields 129.65% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PTNR wins by $12.19M in total portfolio value
10 years
PTNR
PTNR
● Live price
129.65%
Share price
$6.61
Annual div
$8.57
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12.22M
Annual income
$4,856,374.54
Full PTNR calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — PTNR vs JNJ

📍 PTNR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPTNRJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PTNR + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PTNR pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PTNR
Annual income on $10K today (after 15% tax)
$11,020.51/yr
After 10yr DRIP, annual income (after tax)
$4,127,918.36/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, PTNR beats the other by $4,123,932.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PTNR + JNJ for your $10,000?

PTNR: 50%JNJ: 50%
100% JNJ50/50100% PTNR
Portfolio after 10yr
$6.13M
Annual income
$2,430,531.97/yr
Blended yield
39.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PTNR
Analyst Ratings
1
Hold
1
Sell
Consensus: Hold
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PTNR buys
0
JNJ buys
0
No recent congressional trades found for PTNR or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPTNRJNJ
Forward yield129.65%2.13%
Annual dividend / share$8.57$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$12.22M$30.3K
Annual income after 10y$4,856,374.54$4,689.40
Total dividends collected$11.19M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: PTNR vs JNJ ($10,000, DRIP)

YearPTNR PortfolioPTNR Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$23,665$12,965.31$10,592$272.30+$13.1KPTNR
2$53,997$28,675.51$11,289$357.73+$42.7KPTNR
3$118,926$61,148.80$12,123$472.89+$106.8KPTNR
4$253,117$125,865.94$13,141$629.86+$240.0KPTNR
5$521,197$250,362.08$14,408$846.81+$506.8KPTNR
6$1,039,480$481,798.88$16,021$1,151.60+$1.02MPTNR
7$2,010,284$898,040.85$18,122$1,588.22+$1.99MPTNR
8$3,774,136$1,623,131.68$20,930$2,228.20+$3.75MPTNR
9$6,886,260$2,847,934.81$24,792$3,191.91+$6.86MPTNR
10$12,224,673$4,856,374.54$30,274$4,689.40+$12.19MPTNR

PTNR vs JNJ: Complete Analysis 2026

PTNRStock

Partner Communications Company Ltd. provides various telecommunication services in Israel. It operates in two segments, Cellular and Fixed-Line. The company offers cellular telephony services, including basic cellular telephony, text messaging, internet browsing and data transfer, content, handset repair, roaming, and services provided to other operators that are permitted to use its cellular network, as well as Machine to Machine and Internet of Things services. It also provides cellular content and value-added services, such as multimedia messaging, cyber protection, cloud backup, ringtone, music streaming, and various business services; and international roaming services, as well as sells and leases cellular handsets, and related cellular devices and accessories. In addition, the company offers Internet service provider (ISP) services comprising email accounts, Wi-Fi networking, anti-virus and anti-spam filtering, and infrastructure and ISP access; network and data infrastructure services, information security and integration solutions, designated services, business information storage services, and data center and cloud services; international long distance services; fixed-line transmission and data capacity services; and voice over broadband telephony and primary rate interface services. Further, it provides television, high speed broadband fiber optic based network, and value added services; and sells and rents modems, domestic routers, servers, and related equipment, as well as tablets, laptops, datacards, audio accessories and other devices, and integration projects. Additionally, the company offers office communication private branch exchange services to business customers. It offers its services and products through sales and service centers, and direct sales force, as well as through dealers and online. The company was incorporated in 1997 and is headquartered in Rosh HaAyin, Israel.

Full PTNR Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this PTNR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PTNR vs SCHDPTNR vs JEPIPTNR vs OPTNR vs KOPTNR vs MAINPTNR vs ABBVPTNR vs MRKPTNR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.